This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by SAMAAN, N. A. Articles by ORDONEZ, N. G. Search for Related Content PubMed PubMed Citation Articles by SAMAAN, N. A. Articles by ORDONEZ, N. G. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Lung Cancer Thyroid Cancer

Pulmonary Metastasis of Differentiated Thyroid Carcinoma: Treatment Results in 101 Patients^*

Sections of Endocrinology and Nuclear Medicine, Departments of Internal Medicine and Pathology, The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston, Houston, Texas 77030 Charlottesville, Virginia 2290

Address requests for reprints to: Dr. Naguib Samaan, Section of Endocrinology, Department of Internal Medicine, University of Texas M. D. Anderson Hospital and Tumor Institute at Houston, 6723 Bertner Avenue, Houston, Texas 77030.

Well differentiated thyroid carcinoma was diagnosed in 1,127 patients at The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston from 1951 to 1981. Of those 1,127 patients, 101 had documented pulmonary metastasis. A retrospective analysis was conducted, and these patients were followed up until 1983. The primary tumors in these patients were histologically classified as papillary (67%), follicular (22%), or Hurthle cell (11%). The age at diagnosis ranged from 5–87 yr. Lung metastasis was diagnosed by both chest x-ray and positive uptake of ¹³¹I in 49 patients. Forty-two patients had positive chest x-ray results and negative 131I scans, and 10 patients had positive ¹³¹I scans and negative chest x-ray results. The patients were treated with radioactive iodine (76%), chemotherapy (9%), external radiotherapy (2%), or supportive care only (14%). Sixty-seven patients subsequently died of thyroid carcinoma.

Our studies showed the following. 1) Patients who were younger than 40 yr of age at diagnosis had better prognosis (71% survival) compared with those over 40 yr of age (16% survival; P<0.01). 2) Uptake of radioactive iodine by lung metastasis is a favorable prognostic factor, especially in patients with negative radiological findings. Patients treated with radioactive iodine have a longer survival than those not treated with radioactive iodine (P<0.002). 3) The incidence of pulmonary metastasis is significantly less in patients who are treated by total thyroidectomy than in those treated with less than total thyroidectomy (P<0.03). 4) The incidence of pulmonary metastasis is lowest in patients with papillary carcinoma (9%), compared with that in patients with follicular (13%) or Hurthle cell (25%) carcinoma.

^* This work was supported in part by NCI Grant CA-35040-02 and the Nancy Carmichael Gift Fund.

Received August 8, 1984.

This article has been cited by other articles:

				C. Ma, J. Xie, and A. Kuang Is Empiric 131I Therapy Justified for Patients with Positive Thyroglobulin and Negative 131I Whole-Body Scanning Results? J. Nucl. Med., July 1, 2005; 46(7): 1164 - 1170. [Abstract] [Full Text] [PDF]

				C. F. A. Eustatia-Rutten, J. A. Romijn, M. J. Guijt, G. J. Vielvoye, R. van den Berg, E. P. M. Corssmit, A. M. Pereira, and J. W. A. Smit Outcome of Palliative Embolization of Bone Metastases in Differentiated Thyroid Carcinoma J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3184 - 3189. [Abstract] [Full Text] [PDF]

				E. L. Mazzaferri and R. T. Kloos Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1447 - 1463. [Full Text]

				B. Schluter, K. H. Bohuslavizki, W. Beyer, M. Plotkin, R. Buchert, and M. Clausen Impact of FDG PET on Patients with Differentiated Thyroid Cancer Who Present with Elevated Thyroglobulin and Negative 131I Scan J. Nucl. Med., January 1, 2001; 42(1): 71 - 76. [Abstract] [Full Text] [PDF]

				P. Fonseca Thyroid lung metastasis diagnosed 47 years after thyroidectomy Ann. Thorac. Surg., March 1, 1999; 67(3): 856 - 857. [Abstract] [Full Text] [PDF]

				W. J. Wood Jr, S. E. Singletary, and R. C. Hickey Current Results of Treatment for Distant Metastatic Well-Differentiated Thyroid Carcinoma Arch Surg, December 1, 1989; 124(12): 1374 - 1377. [Abstract] [PDF]